Dynamic contrast-enhanced magnetic resonance imaging of prostate cancer: A review of current methods and applications.

Related Articles

Dynamic contrast-enhanced magnetic resonance imaging of prostate cancer: A review of current methods and applications.

World J Radiol. 2017 Dec 28;9(12):416-425

Authors: Mazaheri Y, Akin O, Hricak H

Abstract
In many areas of oncology, dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) has proven to be a clinically useful, non-invasive functional imaging technique to quantify tumor vasculature and tumor perfusion characteristics. Tumor angiogenesis is an essential process for tumor growth, proliferation, and metastasis. Malignant lesions demonstrate rapid extravasation of contrast from the intravascular space to the capillary bed due to leaky capillaries associated with tumor neovascularity. DCE-MRI has the potential to provide information regarding blood flow, areas of hypoperfusion, and variations in endothelial permeability and microvessel density to aid treatment selection, enable frequent monitoring during treatment and assess response to targeted therapy following treatment. This review will discuss the current status of DCE-MRI in cancer imaging, with a focus on its use in imaging prostate malignancies as well as weaknesses that limit its widespread clinical use. The latest techniques for quantification of DCE-MRI parameters will be reviewed and compared.

PMID: 29354207 [PubMed]

http://ift.tt/2rwNxuB